Excel CSV XML Print

₃Christie Ballantyne

Key Opinion Leader In [Christie Ballantyne is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (32) [keywords assigned to Christie Ballantyne articles by PubMed, the leading number and the color conveys importance]

₃Humans | ₂Male | ₂Risk Assessment | ₂Death, Sudden, Cardiac | ₁Leukocytes | ₁Severity of Illness Index | ₁Animals | ₁Monocytes | ₁Consensus | ₁Platelet Glycoprotein GPIIb-IIIa Complex | ₁Time Factors | ₁Membrane Glycoproteins | ₁Flow Cytometry | ₁Inflammation | ₁Mass Screening | ₁Swine | ₁Adult | ₁Platelet Activation | ₁Middle Aged | ₁Macrophage-1 Antigen | ₁Platelet Aggregation | ₁Disease Susceptibility | ₁Female | ₁Biological Markers | ₁Antibodies, Monoclonal | ₁Myocardium | ₁Syndrome | ₁Terminology | ₁Myocardial Infarction | ₁Models, Cardiovascular | ₁Arteriosclerosis | ₁Blood Platelets

Other [context-specific ads]

Christie Ballantyne Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Christie Ballantyne might be a good expert witness on these terms]

₄₆vulnerable | ₁₃patients | ₁₂plaque | ₁₂coronary | ₁₂plaques | ₁₁psgl-1 | ₈risk | ₈assessment | ₈part | ₈patient | ₇disease | ₇blood | ₆myocardium | ₆formation | ₆alone | ₆ii | ₆cardiac | ₅pmcs | ₅combination | ₅will | ₅acute | ₅syndromes | ₅iib | ₄victims | ₄development | ₄heart | ₄myocardial | ₄sudden | ₄future | ₄screening | ₄field | ₄likelihood
₁₀vulnerable patients | ₁₀vulnerable plaque | ₈risk assessment | ₈vulnerable patient | ₈vulnerable plaques | ₆vulnerable myocardium | ₆consensus document | ₅acute coronary | ₅psgl-1 alone | ₅coronary syndromes | ₄vulnerable blood | ₄heart disease | ₄sudden cardiac | ₄coronary heart | ₄cardiac death | ₄part ii | ₄assessment strategies | ₄patient call | ₄plaque vulnerable | ₄call definitions | ₄strategies part | ₄definitions risk | ₄assessment vulnerable | ₃alone combination | ₃platelet-monocyte complex | ₃patients vulnerable | ₃alpha iib | ₃plaques vulnerable | ₃iib beta | ₃complex formation | ₂protein imaging | ₂without prior
₅acute coronary syndromes | ₄sudden cardiac death | ₄coronary heart disease | ₄plaque vulnerable patient | ₄patient call definitions | ₄vulnerable patient call | ₄vulnerable plaque vulnerable | ₄call definitions risk | ₄definitions risk assessment | ₄assessment strategies part | ₄risk assessment strategies | ₄assessment vulnerable patients | ₄risk assessment vulnerable | ₃psgl-1 alone combination | ₃platelet-monocyte complex formation | ₃vulnerable patients vulnerable | ₃alpha iib beta | ₂developed assays eg | ₂relationship vulnerable patients | ₂needs developed may | ₂definition vulnerable plaque | ₂alphaiibbeta3 alphambeta2 coronary | ₂treatment coronary heart | ₂screening diagnostic methods | ₂rapid progression considered | ₂consensus document cover | ₂mri noninvasive electrophysiological | ₂based plaque blood | ₂despite major advances | ₂variables based plaque | ₂recognition role vulnerable | ₂part consensus document

Authoratory™
•home •community •tutorial •authors •keywords •search •top ranked •NEH grants •login	Excel CSV XML Print ₃Christie Ballantyne 2002 \| 2003 \| 2004 >> Summary Social Network Interests Funding Articles Comments All Key Opinion Leader In [Christie Ballantyne is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors] no keywords assigned Keywords (32) [keywords assigned to Christie Ballantyne articles by PubMed, the leading number and the color conveys importance] ₃Humans \| ₂Male \| ₂Risk Assessment \| ₂Death, Sudden, Cardiac \| ₁Leukocytes \| ₁Severity of Illness Index \| ₁Animals \| ₁Monocytes \| ₁Consensus \| ₁Platelet Glycoprotein GPIIb-IIIa Complex \| ₁Time Factors \| ₁Membrane Glycoproteins \| ₁Flow Cytometry \| ₁Inflammation \| ₁Mass Screening \| ₁Swine \| ₁Adult \| ₁Platelet Activation \| ₁Middle Aged \| ₁Macrophage-1 Antigen \| ₁Platelet Aggregation \| ₁Disease Susceptibility \| ₁Female \| ₁Biological Markers \| ₁Antibodies, Monoclonal \| ₁Myocardium \| ₁Syndrome \| ₁Terminology \| ₁Myocardial Infarction \| ₁Models, Cardiovascular \| ₁Arteriosclerosis \| ₁Blood Platelets Other [context-specific ads] Christie Ballantyne Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Christie Ballantyne might be a good expert witness on these terms] ₄₆vulnerable \| ₁₃patients \| ₁₂plaque \| ₁₂coronary \| ₁₂plaques \| ₁₁psgl-1 \| ₈risk \| ₈assessment \| ₈part \| ₈patient \| ₇disease \| ₇blood \| ₆myocardium \| ₆formation \| ₆alone \| ₆ii \| ₆cardiac \| ₅pmcs \| ₅combination \| ₅will \| ₅acute \| ₅syndromes \| ₅iib \| ₄victims \| ₄development \| ₄heart \| ₄myocardial \| ₄sudden \| ₄future \| ₄screening \| ₄field \| ₄likelihood ₁₀vulnerable patients \| ₁₀vulnerable plaque \| ₈risk assessment \| ₈vulnerable patient \| ₈vulnerable plaques \| ₆vulnerable myocardium \| ₆consensus document \| ₅acute coronary \| ₅psgl-1 alone \| ₅coronary syndromes \| ₄vulnerable blood \| ₄heart disease \| ₄sudden cardiac \| ₄coronary heart \| ₄cardiac death \| ₄part ii \| ₄assessment strategies \| ₄patient call \| ₄plaque vulnerable \| ₄call definitions \| ₄strategies part \| ₄definitions risk \| ₄assessment vulnerable \| ₃alone combination \| ₃platelet-monocyte complex \| ₃patients vulnerable \| ₃alpha iib \| ₃plaques vulnerable \| ₃iib beta \| ₃complex formation \| ₂protein imaging \| ₂without prior ₅acute coronary syndromes \| ₄sudden cardiac death \| ₄coronary heart disease \| ₄plaque vulnerable patient \| ₄patient call definitions \| ₄vulnerable patient call \| ₄vulnerable plaque vulnerable \| ₄call definitions risk \| ₄definitions risk assessment \| ₄assessment strategies part \| ₄risk assessment strategies \| ₄assessment vulnerable patients \| ₄risk assessment vulnerable \| ₃psgl-1 alone combination \| ₃platelet-monocyte complex formation \| ₃vulnerable patients vulnerable \| ₃alpha iib beta \| ₂developed assays eg \| ₂relationship vulnerable patients \| ₂needs developed may \| ₂definition vulnerable plaque \| ₂alphaiibbeta3 alphambeta2 coronary \| ₂treatment coronary heart \| ₂screening diagnostic methods \| ₂rapid progression considered \| ₂consensus document cover \| ₂mri noninvasive electrophysiological \| ₂based plaque blood \| ₂despite major advances \| ₂variables based plaque \| ₂recognition role vulnerable \| ₂part consensus document Science Trivia (2) [Interactive math & science trivia questions]

	The content of this page was generated automatically by a computer program. Copyright © 2006-2010 Authoratory.com \| All rights reserved \| Terms of use \| Privacy policy

3Christie Ballantyne

Key Opinion Leader In [Christie Ballantyne is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

Keywords (32) [keywords assigned to Christie Ballantyne articles by PubMed, the leading number and the color conveys importance]

Other [context-specific ads]

Christie Ballantyne Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Christie Ballantyne might be a good expert witness on these terms]

Science Trivia (2) [Interactive math & science trivia questions]

₃Christie Ballantyne